FdaApplication
ANDA 081127
Identifiers
- fda_app_no: ANDA081127
Properties
| Property | Value |
|---|---|
| applicant_name | BEXIMCO PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 1991-06-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HYDROXYZINE PAMOATE | HYDROXYZINE PAMOATE | EQ 25MG HYDROCHLORIDE | CAPSULE;ORAL |
1 product